The poor prognosis of patients expressing the highest levels of BNC2, and the elevated expression of BNC2 at more advanced cancer stages, may be more indicative of infiltrating fibroblasts than it is necessarily that of BNC2 expression in the tumour cells themselves. This evidence concerns the gene BNC2 and neoplasm.